Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

NCT02522481 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Lumason

Sponsor

Bracco Diagnostics, Inc